EP1446008A4 - Compositions et procede pour liberation controlee - Google Patents

Compositions et procede pour liberation controlee

Info

Publication number: EP1446008A4
Authority: EP; European Patent Office
Prior art keywords: compositions; methods; controlled release; release; controlled
Prior art date: 2001-10-18
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP02803289A

Other languages

German (de)

English (en)

Other versions

EP1446008A2 (fr

Inventor

Arthur H Wong

Jacob M Waugh

Michael D Dake

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Revance Therapeuticals Inc

Original Assignee

Essentia Biosystems Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-10-18

Filing date

2002-10-17

Publication date

2006-08-16

2002-10-17 Application filed by Essentia Biosystems Inc filed Critical Essentia Biosystems Inc

2004-08-18 Publication of EP1446008A2 publication Critical patent/EP1446008A2/fr

2006-08-16 Publication of EP1446008A4 publication Critical patent/EP1446008A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/111—General methods applicable to biologically active non-coding nucleic acids
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/13—Decoys
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/317—Chemical structure of the backbone with an inverted bond, e.g. a cap structure
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2320/00—Applications; Uses
- C12N2320/30—Special therapeutic applications
- C12N2320/32—Special delivery means, e.g. tissue-specific

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Biomedical Technology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Immunology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Molecular Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Genetics & Genomics (AREA)
Biotechnology (AREA)
Wood Science & Technology (AREA)
Zoology (AREA)
Physics & Mathematics (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
General Engineering & Computer Science (AREA)
Microbiology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Analytical Chemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Virology (AREA)
Biophysics (AREA)
Pathology (AREA)
General Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Transplantation (AREA)
Plant Pathology (AREA)

EP02803289A 2001-10-18 2002-10-17 Compositions et procede pour liberation controlee Withdrawn EP1446008A4 (fr)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US33634401P	2001-10-18	2001-10-18
US336344P		2001-10-18
PCT/US2002/033558 WO2003060142A2 (fr)	2001-10-18	2002-10-17	Compositions et procede pour liberation controlee

Publications (2)

Publication Number	Publication Date
EP1446008A2 EP1446008A2 (fr)	2004-08-18
EP1446008A4 true EP1446008A4 (fr)	2006-08-16

Family

ID=23315656

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP02803289A Withdrawn EP1446008A4 (fr)	2001-10-18	2002-10-17	Compositions et procede pour liberation controlee

Country Status (5)

Country	Link
EP (1)	EP1446008A4 (fr)
JP (1)	JP2005523890A (fr)
AU (1)	AU2002365136A1 (fr)
CA (1)	CA2464131A1 (fr)
WO (1)	WO2003060142A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2009145813A1 (fr)	2008-03-04	2009-12-03	Qd Vision, Inc.	Particules comprenant des nanoparticules, leurs utilisations, et procédés
EP2475717A4 (fr)	2009-09-09	2015-01-07	Qd Vision Inc	Particules comprenant des nanoparticules, leurs utilisations, et procédés
WO2011031876A1 (fr)	2009-09-09	2011-03-17	Qd Vision, Inc.	Formulations comprenant des nanoparticules
DE102009058769A1 (de) *	2009-12-16	2011-06-22	MagForce Nanotechnologies AG, 10589	Temperaturabhängige Aktivierung von katalytischen Nukleinsäuren zur kontrollierten Wirkstofffreisetzung
JP2016183434A (ja) *	2015-03-26	2016-10-20	国立大学法人京都大学	表面修飾基材
CN115177740A (zh) *	2021-04-01	2022-10-14	安升（上海）医药科技有限公司	核酸自组装介导的adc药物的构建方法及应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998052614A2 (fr) *	1997-05-21	1998-11-26	The Board Of Trustees Of The Leland Stanford Junior University	Composition et procede permettant d'ameliorer les transports a travers des membranes biologiques
US5985554A (en) *	1994-11-02	1999-11-16	Takeda Chemical Industries, Ltd.	Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides
WO2001024775A1 (fr) *	1999-10-01	2001-04-12	Essentia Biosystems, Inc.	Compositions de gelifiant
US6232068B1 (en) *	1999-01-22	2001-05-15	Rosetta Inpharmatics, Inc.	Monitoring of gene expression by detecting hybridization to nucleic acid arrays using anti-heteronucleic acid antibodies
US6333194B1 (en) *	1999-01-19	2001-12-25	The Children's Hospital Of Philadelphia	Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
US6395029B1 (en) *	1999-01-19	2002-05-28	The Children's Hospital Of Philadelphia	Sustained delivery of polyionic bioactive agents
WO2003024455A2 (fr) *	2001-09-17	2003-03-27	Control Delivery Systems, Inc.	Prothese endovasculaire revetue d'un apport de medicaments a liberation prolongee et son procede d'utilisation
WO2003030943A1 (fr) *	2001-10-09	2003-04-17	The University Of British Columbia	Compositions comprenant hydroxyapatite utilisees pour administrer des agents therapeutiques

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1999050462A1 (fr) *	1998-03-27	1999-10-07	President And Fellows Of Harvard College	Systemes d'inhibition bacteriens a base d'aptameres (abbis)

2002
- 2002-10-17 EP EP02803289A patent/EP1446008A4/fr not_active Withdrawn
- 2002-10-17 AU AU2002365136A patent/AU2002365136A1/en not_active Abandoned
- 2002-10-17 JP JP2003560224A patent/JP2005523890A/ja active Pending
- 2002-10-17 WO PCT/US2002/033558 patent/WO2003060142A2/fr not_active Ceased
- 2002-10-17 CA CA002464131A patent/CA2464131A1/fr not_active Abandoned

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5985554A (en) *	1994-11-02	1999-11-16	Takeda Chemical Industries, Ltd.	Method of probing the function of proteins or peptides encoded by partially sequenced cDNAs by inhibiting protein synthesis with antisense oligonucleotides
WO1998052614A2 (fr) *	1997-05-21	1998-11-26	The Board Of Trustees Of The Leland Stanford Junior University	Composition et procede permettant d'ameliorer les transports a travers des membranes biologiques
US6333194B1 (en) *	1999-01-19	2001-12-25	The Children's Hospital Of Philadelphia	Hydrogel compositions for controlled delivery of virus vectors and methods of use thereof
US6395029B1 (en) *	1999-01-19	2002-05-28	The Children's Hospital Of Philadelphia	Sustained delivery of polyionic bioactive agents
US6232068B1 (en) *	1999-01-22	2001-05-15	Rosetta Inpharmatics, Inc.	Monitoring of gene expression by detecting hybridization to nucleic acid arrays using anti-heteronucleic acid antibodies
WO2001024775A1 (fr) *	1999-10-01	2001-04-12	Essentia Biosystems, Inc.	Compositions de gelifiant
WO2003024455A2 (fr) *	2001-09-17	2003-03-27	Control Delivery Systems, Inc.	Prothese endovasculaire revetue d'un apport de medicaments a liberation prolongee et son procede d'utilisation
WO2003030943A1 (fr) *	2001-10-09	2003-04-17	The University Of British Columbia	Compositions comprenant hydroxyapatite utilisees pour administrer des agents therapeutiques

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BIGGINS J B ET AL: "A continuous assay for DNA cleavage: the application of break lights to enediynes, iron-dependent agents, and nucleases", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, vol. 97, no. 25, 5 December 2000 (2000-12-05), pages 13537 - 13542, XP001094000, ISSN: 0027-8424 *
CASSIDY R A ET AL: "Triplex formation by psoralen-conjugated chimeric oligonucleoside methylphosphonates", BIOCHEMISTRY 25 JUL 2000 UNITED STATES, vol. 39, no. 29, 25 July 2000 (2000-07-25), pages 8683 - 8691, XP002355044, ISSN: 0006-2960 *
MIYASHIRO H ET AL: "Analysis of the RNase H activity by fluorescence resonance energy transfer.", NUCLEIC ACIDS SYMPOSIUM SERIES. 2000, no. 44, 2000, pages 55 - 56, XP002377139, ISSN: 0261-3166 *
SOHAIL M ET AL: "Antisense arrays", MOLECULAR CELL BIOLOGY RESEARCH COMMUNICATIONS, vol. 3, no. 2, February 2000 (2000-02-01), pages 67 - 72, XP002377138, ISSN: 1522-4724 *

Also Published As

Publication number	Publication date
AU2002365136A1 (en)	2003-07-30
CA2464131A1 (fr)	2003-07-24
WO2003060142A2 (fr)	2003-07-24
WO2003060142A9 (fr)	2003-08-21
JP2005523890A (ja)	2005-08-11
EP1446008A2 (fr)	2004-08-18
WO2003060142A3 (fr)	2004-02-12
AU2002365136A8 (en)	2003-07-30

Publication	Publication Date	Title
DE60210214D1 (de)	2006-05-18	Zweikomponentbeschichtungszusammensetzung und Verfahren zur Herstellung
DE60042883D1 (de)	2009-10-15	Zusammensetzungen und verfahren zur veränderung der gentranskription
DE60320078D1 (de)	2008-05-15	Prothesenvorrichtung und Verfahren zur Herstellung derselben
DE50113565D1 (de)	2008-03-20	Optoelektronisches bauelement und verfahren zur herstellung
ATE368018T1 (de)	2007-08-15	Gipszusammensetzungen und dazugehörende verfahren
DE60217785D1 (de)	2007-03-15	Flasche und Verfahren zur Herstellung derselben
DE60210265D1 (de)	2006-05-18	Verfahren und zwischenprodukte zur herstellung von 4-aminochinolin-cetp-inhibitoren
ATE398455T1 (de)	2008-07-15	Zusammensetzungen und verfahren zur antiviralen kombinationstherapie
DE60201777D1 (de)	2004-12-09	Formvorrichtung und Verfahren zur Verwendung der Formvorrichtung
DE60301350D1 (de)	2005-09-22	Verfahren zur herstellung von 7-substituierten -3-chinolin und 3-chinol-4-on carbonitrile
DE60108872D1 (de)	2005-03-17	Konzentrat zur schlammeisbereitung und verfahren zur herstellung
DE60235273D1 (de)	2010-03-18	Positive Resistzusammensetzung und Verfahren zur Strukturformung damit
DE60003250D1 (de)	2003-07-17	Reinigungszusammensetzungen und Verfahren zur Reinigung
DE60238459D1 (de)	2011-01-13	Einzelelektron-Speicheranordnung und Verfahren zur Herstellung
EP1227821A4 (fr)	2004-09-22	Compositions therapeutiques et leurs procedes d'utilisation
DE602004005103D1 (de)	2007-04-19	Spulenbauteil und Verfahren zur Herstellung
DE60119685D1 (de)	2006-06-22	Komprimierbare schaumbänder und verfahren zur herstellung
DE60231077D1 (de)	2009-03-19	Resistzusammensetzung und Verfahren zur Herstellung von Halbleiterbauelementen
DE60238742D1 (de)	2011-02-10	Gate-Struktur und Verfahren zur Herstellung
DE60319099D1 (de)	2008-03-27	Kaugummiformulierung und verfahren zur herstellung derselben
DE60213913D1 (de)	2006-09-28	System und Verfahren zur Inhaltsdarstellung
DE60221928D1 (de)	2007-10-04	Steckverbinder und Verfahren zur Herstellung
DK1949936T3 (da)	2011-08-15	Sammensætning til kontrolleret frigivelse og fremgangsmåde til fremstilling deraf
DE50203752D1 (de)	2005-09-01	Spanlos geformter bremssattel und verfahren zur herstellung
EP1455841A4 (fr)	2004-12-08	Compositions et methodes associees a l'osteopontine

Legal Events

Date	Code	Title	Description
2004-07-02	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2004-08-18	17P	Request for examination filed	Effective date: 20040517
2004-08-18	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR
2004-08-18	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2005-04-22	REG	Reference to a national code	Ref country code: HK Ref legal event code: DE Ref document number: 1067848 Country of ref document: HK
2006-08-09	RIC1	Information provided on ipc code assigned before grant	Ipc: G01N 33/58 20060101ALI20060704BHEP Ipc: C12Q 1/68 20060101ALI20060704BHEP Ipc: C07H 21/04 20060101ALI20060704BHEP Ipc: C07H 21/02 20060101ALI20060704BHEP Ipc: C07H 21/00 20060101ALI20060704BHEP Ipc: A01N 43/04 20060101ALI20060704BHEP Ipc: A01N 37/18 20060101ALI20060704BHEP Ipc: C12Q 1/34 20060101AFI20060704BHEP
2006-08-16	A4	Supplementary search report drawn up and despatched	Effective date: 20060714
2006-11-22	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: REVANCE THERAPEUTICS, INC.
2006-11-29	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: REVANCE THERAPEUTICS, INC.
2007-04-25	17Q	First examination report despatched	Effective date: 20070326
2007-05-16	RIN1	Information on inventor provided before grant (corrected)	Inventor name: DAKE, MICHAEL, D. Inventor name: WAUGH, JACOB, M. Inventor name: WONG, ARTHUR, H.
2009-10-09	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2009-11-11	18D	Application deemed to be withdrawn	Effective date: 20090501
2011-06-03	REG	Reference to a national code	Ref country code: HK Ref legal event code: WD Ref document number: 1067848 Country of ref document: HK